FATAL OUTCOMES FROM DRUG INTERACTIONS: INSIGHTS FROM THE FDA ADVERSE EVENT REPORTING SYSTEM

被引：0
|
作者：
Gomez-Lumbreras, A. [1 ]
Villa, Zapata L. [2 ]
Malone, D. [1 ]
机构：
[1] Univ Utah, Dept Pharmacotherapy, Coll Pharm, Salt Lake City, UT USA
[2] Univ Georgia, Coll Pharm, Atlanta, GA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH103
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [1] Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
    Antonazzo, Ippazio Cosimo
    Raschi, Emanuel
    Forcesi, Emanuele
    Riise, Trond
    Bjornevik, Kjetil
    Baldin, Elisa
    De Ponti, Fabrizio
    Poluzzi, Elisabetta
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (09) : 869 - 874
  • [2] MEDICATION-INDUCED TAKOTSUBO SYNDROME: INSIGHTS FROM FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Niu, Haiming
    Yuan, Yong, Sr.
    Li, Jianwei, Sr.
    Shi, Ao
    Cai, Peng
    Chen, Miaolian
    Peddibhotla, Bharath
    Liang, Hongkai
    Feng, Li, Sr.
    Li, Mingxing, Sr.
    Teng, Catherine
    Li, Pengyang
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 740 - 740
  • [3] ADVERSE EVENTS ASSOCIATED WITH COLCHICINE DRUG INTERACTIONS: ANALYSIS OF THE PUBLIC VERSION OF THE FDA ADVERSE EVENT REPORTING SYSTEM
    Almalki, Z.
    Guo, J. J.
    Kelton, C. M.
    Wigle, P. R.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A218 - A218
  • [4] Adverse Events Associated with Colchicine Drug Interactions: Analysis of the Public Version of the FDA Adverse Event Reporting System
    Almalki, Ziyad S.
    Guo, Jeff J.
    Kelton, Christina M. L.
    Wigle, Patricia R.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 83 - 84
  • [5] A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)
    Lorenzo Villa-Zapata
    Ainhoa Gómez-Lumbreras
    John Horn
    Malinda S. Tan
    Richard D. Boyce
    Daniel C. Malone
    [J]. Drug Safety, 2022, 45 : 863 - 871
  • [6] Drug-versus-Drug Adverse Event Rate Comparisons A Pilot Study Based on Data from the US FDA Adverse Event Reporting System
    Hochberg, Alan M.
    Pearson, Ronald. K.
    O'Hara, Donald J.
    Reisinger, Stephanie J.
    [J]. DRUG SAFETY, 2009, 32 (02) : 137 - 146
  • [7] Drug-versus-Drug Adverse Event Rate ComparisonsA Pilot Study Based on Data from the US FDA Adverse Event Reporting System
    Alan M. Hochberg
    Ronald K. Pearson
    Donald J. O’Hara
    Stephanie J. Reisinger
    [J]. Drug Safety, 2009, 32 : 137 - 146
  • [8] Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
    Byskov, Pernille Kahler
    Baden, Christoffer Storm
    Andersen, Jon Traerup
    Jimenez-Solem, Espen
    Olsen, Ramus Huan
    Gade, Christina
    Lausten-Thomsen, Ulrik
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] Interaction between paracetamol and lamotrigine: new insights from the FDA Adverse Event Reporting System (FAERS) database
    Carnovale, Carla
    Mosini, Giulia
    Gringeri, Michele
    Battini, Vera
    Mazhar, Faizan
    Pozzi, Marco
    Clementi, Emilio
    Radice, Sonia
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (09) : 1323 - 1325
  • [10] Interaction between paracetamol and lamotrigine: new insights from the FDA Adverse Event Reporting System (FAERS) database
    Carla Carnovale
    Giulia Mosini
    Michele Gringeri
    Vera Battini
    Faizan Mazhar
    Marco Pozzi
    Emilio Clementi
    Sonia Radice
    [J]. European Journal of Clinical Pharmacology, 2019, 75 : 1323 - 1325
12345